Here are some highlights that particularly caught my attention:

• The Intensifying Injectables Algorithm for Type 2 was simplified and now includes instruction on using NPH in clinical practice.
• There is continued enhancement of the Cardiovascular Standard which provides intensive guidelines to improve care and reduce mortality from heart disease.
• The Microvascular Complication section was updated and new charts were added to clarify screening and diagnostic guidelines.
• In the children and adolescent section, detailed and updated information on cardiovascular risk management, screening and pharmacologic approaches were added.
• The Diabetes Technology section was re-organized and updated in an effort to keep up with the rapid pace of new tech tools that individuals are using to improve diabetes care.